Form 4: Semler Scientific Director Natalie Brunell Granted Stock Options

Semler Scientific, Inc. Director Natalie Brunell was granted 1,125 stock options with an exercise price of $41.04, vesting over six months.

Summary

• Natalie Brunell, a Director of Semler Scientific, Inc. (SMLR), was granted stock options.
• The transaction date for the option grant was June 25, 2025.
• The grant consists of 1,125 stock options, each with an exercise price of $41.04.
• The options are for Common Stock of Semler Scientific, Inc.
• The shares underlying the option will vest over a six-month period: 1/6th on the grant date (June 25, 2025), and then 1/6th on a monthly basis thereafter.
• The stock options have an expiration date of June 25, 2035.
• Following this transaction, Natalie Brunell beneficially owns 1,125 derivative securities (stock options) directly.

Sentiment

Score: 6

Explanation: The document reports a standard compensation event (stock option grant) to a director, which is generally viewed as neutral to slightly positive as it aligns the director's interests with shareholder value, without indicating any immediate operational or financial performance changes.

Positives

• The grant of stock options to a director aligns their financial interests with those of the shareholders, potentially incentivizing long-term company performance.
• This is a standard form of compensation for directors, indicating continued engagement and commitment from the board.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This Form 4 filing details a routine insider transaction, specifically the grant of stock options to a director. Such compensation practices are common across publicly traded companies to attract and retain talent and align management and board interests with shareholder value. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• The grant of stock options as part of director compensation is a widely accepted practice in the U.S. corporate landscape, consistent with governance standards aimed at aligning director incentives with long-term shareholder value creation.
• The vesting schedule of six months is relatively short compared to typical multi-year vesting schedules for executive equity grants, which often span three to five years, though director grants can vary.

Related Party Transactions

• Grant of 1,125 stock options to Natalie Brunell, a Director of Semler Scientific, Inc., with an exercise price of $41.04, as part of her compensation.

Stakeholder Impact

• Shareholders: The grant of stock options to a director can be seen as a positive for shareholders as it aligns the director's financial incentives with the company's stock performance.
• Director (Natalie Brunell): Receives equity compensation, which ties her personal wealth to the company's success.

Next Steps

• The granted stock options will vest over the next six months, with 1/6th of the shares vesting monthly after the initial grant date vesting.

Key Dates

Keywords

Semler Scientific, SMLR, Stock Option, Insider Transaction, Form 4, Director Compensation, Equity Grant, Natalie Brunell